Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
暂无分享,去创建一个
G. Sedvall | C. Halldin | L. Farde | F. Wiesel | C Halldin | L Farde | G Sedvall | F A Wiesel
[1] S. Stone-Elander,et al. No D2 receptor increase in PET study of schizophrenia. , 1987, Archives of general psychiatry.
[2] G. Sedvall,et al. Imaging of neurotransmitter receptors in the living human brain. , 1986, Archives of general psychiatry.
[3] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[4] S. Dahl. Plasma Level Monitoring of Antipsychotic Drugs Clinical Utility , 1986, Clinical pharmacokinetics.
[5] J. Baron,et al. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone. , 1985, European journal of pharmacology.
[6] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[7] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Wyatt,et al. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study. , 1985, Psychopharmacology bulletin.
[9] S. Marder,et al. Costs and benefits of two doses of fluphenazine. , 1984, Archives of general psychiatry.
[10] G. Sedvall,et al. Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine , 1984, Acta psychiatrica Scandinavica. Supplementum.
[11] Jonathan M. Links,et al. Imaging dopamine receptors in the human brain by positron tomography , 1983 .
[12] B. Diamond,et al. Antipsychotic Drug Action: Clinical, Biochemical, and Pharmacological Evidence for Site Specificity of Action , 1983, Clinical neuropharmacology.
[13] M. Larsson,et al. A high-performance liquid chromatographic method for the determination of haloperidol and reduced haloperidol in serum , 1983 .
[14] L L Iversen,et al. Increased brain dopamine and dopamine receptors in schizophrenia. , 1982, Archives of general psychiatry.
[15] S. Peroutka,et al. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. , 1980, The American journal of psychiatry.
[16] R. Baldessarini,et al. What is the best maintenance dose of neuroleptics in schizophrenia? , 1980, Psychiatry Research.
[17] C. Marsden,et al. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. , 1980, European journal of pharmacology.
[18] T. Crow,et al. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. , 1979, Life Science.
[19] G. Sedvall,et al. Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection. , 1979, Journal of chromatography.
[20] C. Marsden,et al. The substituted benzamides--a novel class of dopamine antagonists. , 1979, Life sciences.
[21] G. Sedvall,et al. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine , 1978, Acta psychiatrica Scandinavica.
[22] A Carlsson,et al. Antipsychotic drugs, neurotransmitters, and schizophrenia. , 1978, The American journal of psychiatry.
[23] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.
[24] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[25] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[26] G. Sedvall. A relation between drug concentrations in brain and striatal homovanillic acid levels in chlorpromazine treated rats. , 1975, Life sciences.
[27] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[28] D. Klein. Diagnosis and Drug Treatment of Psychiatric Disorders , 1969, British Journal of Psychiatry.
[29] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[30] A. J. Clark. The Rate of Action of Drugs on Cells , 1937 .